This rating has improved by 8% over the last 12 months. 41% of employees would recommend working at BioGX to a friend and 34% have a positive outlook for the business. BioGX has an overall rating of 2.9 out of 5, based on over 24 reviews left anonymously by employees.
Bio rad glassdoor portable#
solidas Birmingham, Alabama, JBioGX, a global provider of molecular diagnostic solutions, announced that the United States Food and Drug Administration …BioGX Expands FDA EUA with pixl™ Portable qPCR System for its Direct-Sample COVID-19 Assay BIRMINGHAM, Ala.-(BUSINESS WIRE)-BioGX, a global provider of easy molecular diagnostic solutions since 2007, announced that the US FDA has updated their original (June 29, 2021) Direct Sample Xfree™ COVID-19 Emergency Use Authorization to increase the shelf-life of the assay reagent to 15 months.
BioGX Hoover, AL1 month agoBe among the first 25 applicantsSee who BioGX has hired for this roleNo longer accepting applications.
Bio rad glassdoor iso#
BioGX operates in a cGMP compliant environment certified to International Standard ISO 13485.General Inquiries: Phone: +1.205.250.8055 FAX: +1.205.449.8055 Address: 1500 First Ave North, C123 Birmingham, Alabama 35203 USA General Inquiries: Phone: +1.205.250.8055 FAX: +1.205.449.8055 Address: 1500 First Ave North, C123 Birmingham, Alabama 35203 USA About BioGX BioGX, Inc., headquartered in Birmingham, Alabama, and its wholly owned subsidiary BioGX B.V., based in Amsterdam, The Netherlands, (collectively "BioGX"), develop and commercialize molecular diagnostics reagents across diverse applications.
BioGX, Inc., headquartered in Birmingham, Alabama and Dallas, TX, and its wholly owned subsidiary BioGX B.V., based in Amsterdam, The Netherlands, (collectively “BioGX”), operates in a cGMP.BioGX, Inc., headquartered in Birmingham, Alabama and Dallas, TX, and its wholly owned subsidiary BioGX B.V., based in Amsterdam, The Netherlands, (collectively “BioGX”), operates in a cGMP. BioGX, Inc., headquartered in Birmingham, Alabama and Dallas, TX. BioGX is a leading global provider of lyophilized real-time PCR reagents for molecular diagnostics. BioGX Expands FDA EUA with pixl™ Portable qPCR System for its Direct-Sample COVID-19 Assay BIRMINGHAM, Ala.-(BUSINESS WIRE)-BioGX, a global provider of easy molecular diagnostic solutions since 2007, announced that the US FDA has updated their original (June 29, 2021) Direct Sample Xfree™ COVID-19 Emergency Use Authorization to increase the shelf-life of the assay reagent to 15 months. The company applies its proprietary platform-agnostic reagent technology to offer products and contract services across a range of real-time polymerase chain. Biogx BioGX is a company that develops molecular products and provides partner-specified formulation and manufacturing services for molecular reagents on a platform of a partner’s choice.
0 kommentar(er)
